LAM
IBB icon

Lebenthal Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Lebenthal Asset Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-45
Closed -$4K – 469
2016
Q3 		$4K Buy
+45
New +$4.28K ﹤0.01% 873

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Lebenthal Asset Management's IBB Position: Q4 2016 in Review

Lebenthal Asset Management sold out of iShares Biotechnology ETF (IBB) in Q4 2016, closing a stake of 45 shares — an estimated $4K sold.

Lebenthal Asset Management first reported a position in IBB in Q3 2016 and held it in 1 quarter. The position peaked at $4K in Q3 2016. 523 funds tracked by Wall St. Rank hold IBB as of Q4 2016.

  • Lebenthal Asset Management reported no remaining iShares Biotechnology ETF position as of Q4 2016 after selling out during the quarter.
  • Lebenthal Asset Management sold 45 iShares Biotechnology ETF shares in Q4 2016, an estimated $4K.
  • Lebenthal Asset Management first reported a position in iShares Biotechnology ETF in Q3 2016 and held it in 1 quarter.
  • Lebenthal Asset Management's iShares Biotechnology ETF position peaked at $4K in Q3 2016.
  • 523 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2016.

Based on Lebenthal Asset Management's 13F filing for Q4 2016, filed 15 Feb 2017.